All In MedTech

FDA Clearance Tracker · P170003-S001

Lutonix Drug Coated Balloon

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 26, 2018 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P170003-S001
Device name
Lutonix Drug Coated Balloon
Applicant
Lutonix
Applicant location
New Hope, MN
Received
Sep 25, 2017
Decided
Feb 26, 2018
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol - OSB
Original approval
P170003

Device type

Device class
Class III

Every decision under product code PRC

FDA's approval statement

As written in FDA's record.

Approval of the protocol for the post-approval study (PAS) protocol.

Source documents

Other decisions for Lutonix

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.